|
"pei jer chen"的相关文件
显示项目 786-795 / 883 (共89页)
<< < 74 75 76 77 78 79 80 81 82 83 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone
|
Kao, J.-H.; Lai, M.-Y.; Chen, W.; Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:52:13Z |
Precore stop codon mutant in chronic hepatitis B virus infection in children: Its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen
|
Chang, M.-H. and Hsu, H.-Y. and Ni, Y.-H. and Tsai, K.-S. and Lee, P.-I. and Chen, P.-J. and Hsu, Y.-L. and Chen, D.-S.; HONG-YUAN HSU; PING-ING LEE; KEH-SUNG TSAI; MEI-HWEI CHANG; PEI-JER CHEN; DING-SHINN CHEN; Yen-Hsuan Ni |
| 臺大學術典藏 |
2018-09-10T06:49:56Z |
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization
|
PEI-JER CHEN; LI-MIN HUANG; CHUN-YI LU; CHIN-YUN LEE; DING-SHINN CHEN; Yen-Hsuan Ni; Lu, C.-Y. and Ni, Y.-H. and Chiang, B.-L. and Chen, P.-J. and Chang, M.-H. and Chang, L.-Y. and Su, I.-J. and Kuo, H.-S. and Huang, L.-M. and Chen, D.-S. and Lee, C.-Y.; BOR-LUEN CHIANG; LUAN-YIN CHANG; MEI-HWEI CHANG |
| 臺大學術典藏 |
2018-09-10T06:41:18Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
|
Wang-Huei Sheng; Jia-Horng Kao; Pei-Jer Chen; Li-Ming Huang; Sui-Yuan Chang; Hsin-Yun Sun; Chien-Ching Hung; Mao-Yuan Chen; Shan-Chwen Chang; LI-MIN HUANG |
显示项目 786-795 / 883 (共89页)
<< < 74 75 76 77 78 79 80 81 82 83 > >>
每页显示[10|25|50]项目
|
